When ATA B cells with lymphoma versus nonlymphoma were analyzed at the 12–24 mo stage Fig. 5C, we found that the high ATA B lymphomas lacked both CD1d and IL-5R expression and had increased CD11b/Mac1, as previously shown10. This evidence concerns the gene CD1D and lymphoma.